Abstract
The novel coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), was announced as a pandemic in March 2020. Different diagnostic laboratory tests have been used to detect the infection. Each diagnostic tool, such as Chest Computed tomography (CT) imaging, genome sequencing, nucleic acid amplification methods, whole genome sequencing, microarray, and serology testing have several advantages and disadvantages. Nucleic acid amplification methods are better diagnostic tools for the detection of SARS-CoV-2 in early stages of the infection, while serological tests are more appropriate for the recognition of previously infected patients. In this review, we will briefly consider each diagnostic method, and discuss its pros and cons.
Keywords: COVID-19, SARS-CoV-2, Diagnosis, Polymerase chain reaction, Computed tomography, Serology.
Graphical Abstract
Infectious Disorders - Drug Targets
Title:SARS-CoV-2: An Insight into Detection Tools
Volume: 21 Issue: 8
Author(s): Shaghayegh Khanmohammadi, Mohammadreza Tabary, Farnaz Araghi and Seyed Mohammad Tavangar*
Affiliation:
- Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran,Iran
Keywords: COVID-19, SARS-CoV-2, Diagnosis, Polymerase chain reaction, Computed tomography, Serology.
Abstract: The novel coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), was announced as a pandemic in March 2020. Different diagnostic laboratory tests have been used to detect the infection. Each diagnostic tool, such as Chest Computed tomography (CT) imaging, genome sequencing, nucleic acid amplification methods, whole genome sequencing, microarray, and serology testing have several advantages and disadvantages. Nucleic acid amplification methods are better diagnostic tools for the detection of SARS-CoV-2 in early stages of the infection, while serological tests are more appropriate for the recognition of previously infected patients. In this review, we will briefly consider each diagnostic method, and discuss its pros and cons.
Export Options
About this article
Cite this article as:
Khanmohammadi Shaghayegh , Tabary Mohammadreza, Araghi Farnaz and Tavangar Mohammad Seyed *, SARS-CoV-2: An Insight into Detection Tools, Infectious Disorders - Drug Targets 2021; 21 (8) : e160921189885 . https://dx.doi.org/10.2174/1871526520666210104151849
DOI https://dx.doi.org/10.2174/1871526520666210104151849 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2
Current Pharmaceutical Design Review on Diagnostic Methods for SARS-CoV-2
Coronaviruses Covid-19 Susceptibility and Severity Might be Modified by Vitamin D Status: Theoretical and Practical Considerations
Current Respiratory Medicine Reviews Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check
Current Pharmaceutical Biotechnology Flu Viral Multiplex Testing and its Implication for COVID-19 Testing
New Emirates Medical Journal COVID-19: An Insight on the Third Respiratory Global Emergency of the Century
Coronaviruses ACE2; an ACE up the Sleeve?
Current Enzyme Inhibition Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview
Current Molecular Medicine Potential Pathway that Could Treat Coronaviruses (COVID-19)
Current Biochemical Engineering (Discontinued) Alternative Medicine as a Treatment Option for COVID-19
Current Traditional Medicine Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the <i>“Cytokine Release (Storm) Syndrome”</i> Caused by SARS-CoV-2?
Current Pharmaceutical Design Withdrawal Notice: Therapeutic Options for Treatment of COVID-19: A Review from Repurposed Drugs to New Drug Targets
Current Drug Targets Coronavirus (COVID-19) Outbreak: A Test of Viral Muscle Versus the Human Tussle
Applied Clinical Research, Clinical Trials and Regulatory Affairs The Role of Justicia adhatoda as Prophylaxis for COVID-19 – Analysis Based on Docking
Infectious Disorders - Drug Targets miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis
Current Pharmaceutical Design Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed
Current Medicinal Chemistry High Throughput Bioassays Using Nanoparticles
Combinatorial Chemistry & High Throughput Screening Remdesivir, A Potential Drug for COVID-19 Treatment: A New Hope
Coronaviruses Antifibrotic Drugs for COVID-19: From Orphan Drugs to Blockbusters?
Current Respiratory Medicine Reviews